These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24435454)

  • 41. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicle size indicates oocyte maturity and blastocyst formation but not blastocyst euploidy following controlled ovarian hyperstimulation of oocyte donors.
    McCulloh DH; Kutchukhidze N; Charkviani T; Zhorzholadze T; Barbakadze T; Munné S; Chkonia L
    Hum Reprod; 2020 Mar; 35(3):545-556. PubMed ID: 32142586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The appearance of one-pronuclear human oocytes is associated with a better ovulation-induction response and successful pregnancy outcome.
    Jackson KV; Nureddin A; Clarke RN; Hornstein MD; Rein MS; Friedman AJ
    Fertil Steril; 1992 Aug; 58(2):366-72. PubMed ID: 1633904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.
    Moffat R; Hansali C; Schoetzau A; Ahler A; Gobrecht U; Beutler S; Raggi A; Sartorius G; De Geyter C
    Hum Reprod; 2021 Mar; 36(4):987-997. PubMed ID: 33367742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [CHALLENGING THE OPTIMAL NUMBER OF RETRIEVED OOCYTES AND ITS IMPACT ON PREGNANCY AND LIVE BIRTH RATES IN IVF/ICSI CYCLES].
    Blais I; Lahav-Baratz S; Koifman M; Wiener-Megnazi Z; Auslender R; Dirnfeld M
    Harefuah; 2015 Jun; 154(6):350-5, 406. PubMed ID: 26281076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study.
    Murber A; Fancsovits P; Ledó N; Gilán ZT; Rigó J; Urbancsek J
    Reprod Biol Endocrinol; 2009 Sep; 7():103. PubMed ID: 19781070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years.
    Avrech OM; Royburt M; Sabah G; Zukerman Z; Pinkas H; Amit S; Ovadia J; Fisch B
    J Assist Reprod Genet; 1996 May; 13(5):395-400. PubMed ID: 8739055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.
    Cimadomo D; Vaiarelli A; Colamaria S; Trabucco E; Alviggi C; Venturella R; Alviggi E; Carmelo R; Rienzi L; Ubaldi FM
    Hum Reprod; 2018 Aug; 33(8):1442-1448. PubMed ID: 29912374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of growth hormone on in vitro maturation of germinal vesicle of human oocytes retrieved from small antral follicles.
    Hassan HA; Azab H; Rahman AA; Nafee TM
    J Assist Reprod Genet; 2001 Aug; 18(8):417-20. PubMed ID: 11599461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
    Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcomes from mature oocytes derived from preovulatory and antral follicles: reflections on follicle physiology and oocyte competence.
    Fadini R; Coticchio G; Brambillasca F; Mignini Renzini M; Novara PV; Brigante C; De Ponti E; Dal Canto M
    J Assist Reprod Genet; 2015 Feb; 32(2):255-61. PubMed ID: 25449291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian response in three consecutive in vitro fertilization cycles.
    Hoveyda F; Engmann L; Steele J; Lopez Bernal A; Barlow DH
    Fertil Steril; 2002 Apr; 77(4):706-10. PubMed ID: 11937120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
    Lind T; Holte J; Olofsson JI; Hadziosmanovic N; Gudmundsson J; Nedstrand E; Lood M; Berglund L; Rodriguez-Wallberg K
    Hum Reprod; 2018 Feb; 33(2):238-247. PubMed ID: 29211889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Live birth of twins after performing early hCG administration as a modification of natural cycle in vitro fertilization, in a women with decreased ovarian reserve.
    Hyman JH; Sokal-Arnon T; Son WY; Tan SL; Dahan MH
    Arch Gynecol Obstet; 2015 Jan; 291(1):219-22. PubMed ID: 25033719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study.
    Päkkilä M; Räsänen J; Heinonen S; Tinkanen H; Tuomivaara L; Mäkikallio K; Hippeläinen M; Tapanainen JS; Martikainen H
    Hum Reprod; 2005 Aug; 20(8):2211-4. PubMed ID: 15817582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fertilization, embryo development, and clinical outcome of immature oocytes obtained from natural cycle in vitro fertilization.
    Son WY; Chung JT; Das M; Buckett W; Demirtas E; Holzer H
    J Assist Reprod Genet; 2013 Jan; 30(1):43-7. PubMed ID: 23179385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF?].
    Haas J; Zilberberg E; Kedem A; Dar S; Orvieto R
    Harefuah; 2015 Feb; 154(2):114-7, 135. PubMed ID: 25856865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.